Related Experiment Video
Updated: Dec 9, 2025
03:47
Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
1.3K
Bupropion in dermatology: A brief update.
Israel González-Urbieta1, Mohammad Jafferany2, Julio Torales1
1Department of Psychiatry, School of Medical Sciences, National University of Asunción, San Lorenzo, Paraguay.
Dermatologic Therapy
|September 14, 2020
Summary
Antidepressants may treat skin disorders by reducing inflammation. Current evidence for bupropion in dermatology is limited, primarily from a pilot study and case report, warranting further research.
Area of Science:
- Dermatology
- Pharmacology
- Psychiatry
Background:
- Growing interest in antidepressants for primary cutaneous disorders.
- Proposed anti-inflammatory mechanisms of antidepressants require clinical validation.
- Limited evidence exists for bupropion's dermatologic applications.
Purpose of the Study:
- To review and structure current information on antidepressants, specifically bupropion, for treating dermatologic conditions.
- To guide future research into the efficacy of bupropion in dermatology.
Main Methods:
- Review of existing literature, including a pilot study and case report on bupropion in dermatologic conditions.
- Analysis of proposed anti-inflammatory effects of antidepressants.
Main Results:
- Evidence for bupropion in dermatology is currently sparse.
- The clinical relevance of antidepressant anti-inflammatory effects in skin disorders is not well-established.
Conclusions:
- Bupropion's role in treating primary cutaneous disorders needs more rigorous investigation.
- Further research is essential to establish clinical guidelines for antidepressant use in dermatology.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
652
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
652
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.1K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.1K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
373
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
373
01:19Management of Insomnia
423
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
423
01:25Antidepressant Drugs: Overview
1.2K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.2K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
490
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
490